Original Research

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

Liu W, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, Zhao M

International Journal of Nanomedicine 2019, 14:7263-7279

Published Date: 6 September 2019